Skip to main content
. 2020 Dec 3;15(12):e0242928. doi: 10.1371/journal.pone.0242928

Fig 1. Percentages of axial flow LVAD recipients 2010–2015 meeting key clinical trial exclusion criteria.

Fig 1

†Not on Warfarin.